Chang Xindi, Zheng Wang, Zhao Yingli, Niku Wangkang, Deng Bing, Liu Ping, Wang Yiru
Department of Cardiology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
Vasc Health Risk Manag. 2024 Dec 6;20:541-551. doi: 10.2147/VHRM.S488424. eCollection 2024.
Studies consistently show abnormally high levels of lactate acid in cardiovascular disease patients, suggested that targeting lactate production may serve as potential strategies for the treatment in the future. However, observational results may be subject to residual confounding and bias.
This study used the dataset from GWAS database to examine confounding in epidemiologic associations between lactate and cardiovascular diseases. A genome-wide genetic association study using Mendelian randomization (MR) was performed from December 02, 2023 to January 15, 2024 to reduce confounding and enhance causal inference. Primary analysis was conducted using inverse-variance-weighted MR. All studies included patients predominantly of European ancestry.
The association between lactate and cardiovascular diseases, including 60801 cases from coronary heart disease, 7018 cases from myocardial infarction, 14334 cases from coronary atherosclerosis, 60620 cases from atrial fibrillation, 54358 cases from hypertension, 71 cases from hypertrophic cardiomyopathy, 47309 cases from heart failure, 7055 cases from stroke, 7193 cases from cardioembolic ischemic stroke, 4373 cases from ischemic stroke caused by large vascular atherosclerosis, 2118 cases from pulmonary embolism, 1230 cases from peripheral artery disease, and 4620 cases from venous thromboembolism. Genetically predicted coronary atherosclerosis was associated with a higher risk of lactate level (OR = 1.950; 95% CI (0.087, 1.249); = 0.024); this association was also evident for peripheral artery disease (OR = 1.003; 95% CI (0.000, 0.005); = 0.021). No genetically predicted associations were noted for the other cardiovascular diseases.
The findings of this study provide genetic evidence supporting a higher risk of lactate level only in coronary atherosclerosis and peripheral artery disease. However, no genetic association between lactate level and the other cardiovascular diseases.
研究一致表明心血管疾病患者体内乳酸水平异常高,这表明针对乳酸生成进行干预可能成为未来潜在的治疗策略。然而,观察性结果可能存在残余混杂因素和偏差。
本研究使用了GWAS数据库中的数据集来检验乳酸与心血管疾病之间流行病学关联中的混杂因素。于2023年12月2日至2024年1月15日进行了一项采用孟德尔随机化(MR)的全基因组遗传关联研究,以减少混杂因素并增强因果推断。主要分析采用逆方差加权MR。所有研究纳入的患者主要为欧洲血统。
乳酸与心血管疾病之间的关联,包括来自冠心病的60801例、心肌梗死的7018例、冠状动脉粥样硬化的14334例、心房颤动的60620例、高血压的54358例、肥厚型心肌病的71例、心力衰竭的47309例、中风的7055例、心源性缺血性中风的7193例、大动脉粥样硬化所致缺血性中风的4373例、肺栓塞的2118例、外周动脉疾病的1230例以及静脉血栓栓塞的4620例。遗传预测的冠状动脉粥样硬化与较高的乳酸水平风险相关(比值比=1.950;95%置信区间(0.087,1.249);P=0.024);这种关联在外周动脉疾病中也很明显(比值比=1.003;95%置信区间(0.000,0.005);P=0.021)。对于其他心血管疾病,未发现遗传预测的关联。
本研究结果提供了遗传证据,支持仅在冠状动脉粥样硬化和外周动脉疾病中乳酸水平存在较高风险。然而,乳酸水平与其他心血管疾病之间不存在遗传关联。